SoftOx Solutions AS — Capital/Financing Update 2021

Mar 3, 2021

SoftOx Solutions AS: Last day of the subscription period in the Subsequent Offering

SoftOx Solutions AS: Last day of the subscription period in the Subsequent Offering

Reference is made to the stock exchange announcement from SoftOx Solutions AS (the "Company") on 16 February 2021 regarding the commencement of the subscription period in the subsequent offering of up to 181,818 new shares at a subscription price of NOK 55 per offer share directed towards eligible shareholders as of 16 December 2020 (as registered in the VPS on 18 December 2020) who did not participate in the private placement successfully completed

on the 16 December 2020 (the "Subsequent Offering").

The subscription period for the Subsequent Offering will expire today, on 3 March 2021 at 16:30 (CEST). In order to subscribe for offer shares, SpareBank 1 Markets AS (the "Manager") must receive a complete and duly signed subscription form within 16:30 today.

Subscription rights that are not used to subscribe for offer shares before the expiry of the subscription period will have no value and will lapse without compensation to the holder.

For further information, please refer to the national prospectus available on the Company's website www.soft-ox.com, the Manager's website www.sb1markets.no and that may be ordered from the Norwegian Register of Business Enterprises (Nw: Foretaksregisteret).

For further information, please contact:

Geir Almås, CEO of SoftOx Solutions AS, or

Kristine Rød, FM of SoftOx Solutions AS

Mail: ir@soft-ox.com

Mobile: +47 977 59 071

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian MedTech company based in Oslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com